Showing results (1341-1350 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1986
Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human useE C Beuvery, G J Speijers, B I Lutz, et al.Developments in Biological Standardization|January 1, 1976
Examination of differences between foot-and-mouth disease virus strains using a radioimmunoassay techinqueJ R CrowtherDevelopments in Biological Standardization|January 1, 1976
[Classification of strains of foot-and-mouth disease virus according to the relationship-dominance model for a better understanding of the concept of serologic and immunologic subtype]Y Moreau, C Stellmann, A Brun, et al.Developments in Biological Standardization|January 1, 1976
Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluatesK BauerDevelopments in Biological Standardization|January 1, 1976
[Combined vaccines including 1 or several anti-foot-and-mouth valences]J Fontaine, H Favre, L Valette, et al.Developments in Biological Standardization|May 15, 1998
Influence of several adjuvants on the immune response against a recombinant meningococcal high molecular weight antigenS González, C Nazábal, L Viña, et al.Developments in Biological Standardization|January 1, 1976
[Immunization of ewes against experimental Brucella melitensis infection: comparison of eleven vaccines]R Gaumont, D Trap, G Gayot, et al.Developments in Biological Standardization|January 1, 1997
FDA perspective on specifications for biotechnology products--from IND to PLAG MuranoDevelopments in Biological Standardization|January 1, 1997
Specifications from a biotechnology industry perspectiveR L GarnickDevelopments in Biological Standardization|January 1, 1997
The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnologyR Thorpe, M Wadhwa, A Mire-SluisPageof 220